296 related articles for article (PubMed ID: 20627891)
1. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
Wasserman NF; Aneas I; Nobrega MA
Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
[TBL] [Abstract][Full Text] [Related]
2. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
Pomerantz MM; Ahmadiyeh N; Jia L; Herman P; Verzi MP; Doddapaneni H; Beckwith CA; Chan JA; Hills A; Davis M; Yao K; Kehoe SM; Lenz HJ; Haiman CA; Yan C; Henderson BE; Frenkel B; Barretina J; Bass A; Tabernero J; Baselga J; Regan MM; Manak JR; Shivdasani R; Coetzee GA; Freedman ML
Nat Genet; 2009 Aug; 41(8):882-4. PubMed ID: 19561607
[TBL] [Abstract][Full Text] [Related]
3. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.
Tuupanen S; Turunen M; Lehtonen R; Hallikas O; Vanharanta S; Kivioja T; Björklund M; Wei G; Yan J; Niittymäki I; Mecklin JP; Järvinen H; Ristimäki A; Di-Bernardo M; East P; Carvajal-Carmona L; Houlston RS; Tomlinson I; Palin K; Ukkonen E; Karhu A; Taipale J; Aaltonen LA
Nat Genet; 2009 Aug; 41(8):885-90. PubMed ID: 19561604
[TBL] [Abstract][Full Text] [Related]
4. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk.
Salinas CA; Kwon E; Carlson CS; Koopmeiners JS; Feng Z; Karyadi DM; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1203-13. PubMed ID: 18483343
[TBL] [Abstract][Full Text] [Related]
5. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer.
Walavalkar K; Saravanan B; Singh AK; Jayani RS; Nair A; Farooq U; Islam Z; Soota D; Mann R; Shivaprasad PV; Freedman ML; Sabarinathan R; Haiman CA; Notani D
Nat Commun; 2020 Jul; 11(1):3598. PubMed ID: 32680982
[TBL] [Abstract][Full Text] [Related]
6. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.
Kim T; Cui R; Jeon YJ; Lee JH; Lee JH; Sim H; Park JK; Fadda P; Tili E; Nakanishi H; Huh MI; Kim SH; Cho JH; Sung BH; Peng Y; Lee TJ; Luo Z; Sun HL; Wei H; Alder H; Oh JS; Shim KS; Ko SB; Croce CM
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4173-8. PubMed ID: 24594601
[TBL] [Abstract][Full Text] [Related]
7. Long-range enhancers on 8q24 regulate c-Myc.
Sotelo J; Esposito D; Duhagon MA; Banfield K; Mehalko J; Liao H; Stephens RM; Harris TJ; Munroe DJ; Wu X
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3001-5. PubMed ID: 20133699
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors.
Sur IK; Hallikas O; Vähärautio A; Yan J; Turunen M; Enge M; Taipale M; Karhu A; Aaltonen LA; Taipale J
Science; 2012 Dec; 338(6112):1360-3. PubMed ID: 23118011
[TBL] [Abstract][Full Text] [Related]
9. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
Wright JB; Brown SJ; Cole MD
Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
[TBL] [Abstract][Full Text] [Related]
11. Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.
Glinskii AB; Ma S; Ma J; Grant D; Lim CU; Guest I; Sell S; Buttyan R; Glinsky GV
Cell Cycle; 2011 Oct; 10(20):3571-97. PubMed ID: 22067658
[TBL] [Abstract][Full Text] [Related]
12. A Rare Missense Variant in TCF7L2 Associates with Colorectal Cancer Risk by Interacting with a GWAS-Identified Regulatory Variant in the MYC Enhancer.
Chang J; Tian J; Yang Y; Zhong R; Li J; Zhai K; Ke J; Lou J; Chen W; Zhu B; Shen N; Zhang Y; Gong Y; Zhu Y; Zou D; Peng X; Huang K; Miao X
Cancer Res; 2018 Sep; 78(17):5164-5172. PubMed ID: 30026326
[TBL] [Abstract][Full Text] [Related]
13. An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice.
Ting MC; Liao CP; Yan C; Jia L; Groshen S; Frenkel B; Roy-Burman P; Coetzee GA; Maxson R
Dis Model Mech; 2012 May; 5(3):366-74. PubMed ID: 22279083
[TBL] [Abstract][Full Text] [Related]
14. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
[TBL] [Abstract][Full Text] [Related]
15. Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry.
Pal P; Xi H; Guha S; Sun G; Helfand BT; Meeks JJ; Suarez BK; Catalona WJ; Deka R
Prostate; 2009 Oct; 69(14):1548-56. PubMed ID: 19562729
[TBL] [Abstract][Full Text] [Related]
16. In vivo exploration of the functional activity of the non-coding 8q24 prostate cancer risk locus.
Lamb DJ; Tannour-Louet M
Asian J Androl; 2010 Nov; 12(6):787-9. PubMed ID: 20818410
[No Abstract] [Full Text] [Related]
17. 8q24 and prostate cancer: association with advanced disease and meta-analysis.
Cheng I; Plummer SJ; Jorgenson E; Liu X; Rybicki BA; Casey G; Witte JS
Eur J Hum Genet; 2008 Apr; 16(4):496-505. PubMed ID: 18231127
[TBL] [Abstract][Full Text] [Related]
18. The Crohn's disease associated SNP rs6651252 impacts MYC gene expression in human colonic epithelial cells.
Matthews SM; Eshelman MA; Berg AS; Koltun WA; Yochum GS
PLoS One; 2019; 14(2):e0212850. PubMed ID: 30794691
[TBL] [Abstract][Full Text] [Related]
19. [Association of chromosome 8q24 variants with prostate cancer risk in the Siberian region of Russia and meta-analysis].
Os'kina NA; Boiarskikh UA; Lazarev AF; Petrova VD; Ganov DI; Tonacheva OG; Lifshits GI; Filipenko ML
Mol Biol (Mosk); 2012; 46(2):234-41. PubMed ID: 22670519
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
Pomerantz MM; Beckwith CA; Regan MM; Wyman SK; Petrovics G; Chen Y; Hawksworth DJ; Schumacher FR; Mucci L; Penney KL; Stampfer MJ; Chan JA; Ardlie KG; Fritz BR; Parkin RK; Lin DW; Dyke M; Herman P; Lee S; Oh WK; Kantoff PW; Tewari M; McLeod DG; Srivastava S; Freedman ML
Cancer Res; 2009 Jul; 69(13):5568-74. PubMed ID: 19549893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]